Omeros (OMER) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.79% |
| Dec 31, 2025 | -7.07% |
| Sep 30, 2025 | -7.40% |
| Jun 30, 2025 | -6.35% |
| Mar 31, 2025 | -6.34% |
| Dec 31, 2024 | -6.90% |
| Sep 30, 2024 | -12.53% |
| Jun 30, 2024 | -13.43% |
| Mar 31, 2024 | -16.63% |
| Dec 31, 2023 | -12.70% |
| Sep 30, 2023 | -7.39% |
| Jun 30, 2023 | -6.41% |
| Mar 31, 2023 | -8.50% |
| Dec 31, 2022 | -6.79% |
| Sep 30, 2022 | 0.69% |
| Jun 30, 2022 | 6.14% |
| Mar 31, 2022 | 3.64% |
| Dec 31, 2021 | 7.95% |
| Sep 30, 2021 | 8.71% |
| Jun 30, 2021 | 8.80% |
| Mar 31, 2021 | 19.33% |
| Dec 31, 2020 | 21.82% |
| Sep 30, 2020 | 29.56% |
| Jun 30, 2020 | 31.56% |
| Mar 31, 2020 | 35.78% |
| Dec 31, 2019 | 37.40% |
| Sep 30, 2019 | 34.95% |
| Jun 30, 2019 | 35.76% |
| Mar 31, 2019 | 35.27% |
| Dec 31, 2018 | 32.57% |
| Sep 30, 2018 | 21.49% |
| Jun 30, 2018 | 19.95% |
| Mar 31, 2018 | 14.49% |
| Dec 31, 2017 | 15.39% |
| Sep 30, 2017 | 21.11% |
| Jun 30, 2017 | 16.66% |
| Mar 31, 2017 | 10.85% |
| Dec 31, 2016 | 9.83% |
| Sep 30, 2016 | 7.68% |
| Jun 30, 2016 | 5.61% |
| Dec 31, 2015 | -10.13% |